Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohammed Hoque

Vascular & Interventional Radiology Las Vegas, NV Medical Doctor

NPI 1336482702 CMS profile 4577353

2020 Palomino Ln Ste 100, Las Vegas, NV 89106

Open in the dashboard

General payments

$78,054

483 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mohammed Hoque of Las Vegas, NV is reported in the CMS Open Payments database as having received $78,054 across 483 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,430 34
2024 General $40,064 134
2023 General $19,552 156
2022 General $7,418 72
2021 General $5,069 55
2020 General $2,087 27
2019 General $434 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohammed Hoque
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Mohammed Hoque were reported at $3,430. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Mohammed Hoque Vascular & Interventional Radiology median Middle half National median
2019 $434 $422 $125–$1,555 $163
2020 $2,087 $200 $68–$652 $114
2021 $5,069 $280 $99–$866 $132
2022 $7,418 $433 $137–$1,497 $149
2023 $19,552 $506 $152–$2,019 $160
2024 $40,064 $556 $175–$1,930 $164
2025 $3,430 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $37,158 127 payments
  2. Medtronic, Inc. $20,357 130 payments
  3. Inari Medical, Inc. $5,269 47 payments
  4. Sirtex Medical Inc $3,991 32 payments
  5. Boston Scientific Corporation $3,934 61 payments
  6. Stryker Corporation $1,741 18 payments
  7. AngioDynamics, Inc. $915 8 payments
  8. Medtronic USA, Inc. $561 10 payments
  9. Siemens Medical Solutions USA, Inc. $483 5 payments
  10. W. L. Gore & Associates, Inc. $474 4 payments
  11. Other $3,173 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $37,620 417 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,275 12 payments
  3. Travel and Lodging $15,509 53 payments
  4. Consulting Fee $650 1 payment
Products named General payments · program years 2019–2025
  1. Indigo System $29,781 86 payments
  2. HawkOne $8,833 40 payments
  3. CT THROMBECTOMY SYSTEM KIT $5,488 49 payments
  4. FLOWTRIEVER CATHETER, S $5,488 49 payments
  5. IN.PACT Admiral $4,703 10 payments
  6. SIR-Spheres Microspheres $3,991 32 payments
  7. RUBY Coil $3,171 9 payments
  8. Penumbra System $2,472 13 payments
  9. KYPHON EXPRESS II KYPHOPAK TRAY $1,990 31 payments
  10. TurboHawk $1,576 12 payments
  11. Other $15,546 192 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 163 billing codes

Paid by Medicare

$60,649

Medicare's payments for the services billed

Medicare patients

1,610

Average age 75

Services billed

3,050

876 women, 734 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Chronic kidney disease 47%
Ischemic heart disease 46%
Diabetes 45%
Heart failure 42%
Atrial fibrillation 38%
COPD 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

483 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record